Friday, August 7, 2020
Epirubicin-loaded nanomedicines beat immune checkpoint blockade resistance in glioblastoma
Researchers successfully developed a nanomedicine-based strategy for chemo-immunotherapy of glioblastoma, which has the worst prognosis among brain tumors.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Researchers successfully developed a nanomedicine-based strategy for chemo-immunotherapy of glioblastoma, which has the worst prognosis among brain tumors.
No comments:
Post a Comment